CIRCULOGENE
Dr. J. Kevin Day, Ph.D. is a seasoned laboratory operations leader in the clinical diagnostics arena. His approach for laboratory excellence is the use of Lean Six Sigma methodologies to engage team members in driving continuous improvement initiatives and quality and cost efficiencies into laboratory processes. Dr. Day is certified through the American Board of Bioanalysis (ABB) as a High Complexity Clinical Laboratory Director (HCLD). His greater than 20 years of laboratory operations experience was gained across a broad diversity of genetic and genomic-based diagnostic testing methods (including Next Generation Sequencing) in a testing environment regulated by CAP, CLIA, New York State, AABB, and ISO 17025 and ISO 9001. Dr. Day did his doctoral studies at the University of Missouri-Columbia in Biochemical Genetics and his bachelor’s and master’s degrees at Brigham Young University in Molecular Biology.
This person is not in any offices
CIRCULOGENE
Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence.